1160.67.11009 Boehringer Ingelheim Investigational Site

Calgary, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Coronary Disease

Studies at this site

• RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome — Completed